My take on this morning’s GetBusy update: a quietly strong release from a business that’s starting to look like it’s hitting its stride. Group ARR up 11% to £23.4m is solid, but the real story is SmartVault – ARR up 19% and new business up 36% through the critical US pre-tax season is genuinely impressive. […]
My take on this morning’s Greggs update: solid, but not the upgrade some were hoping for. Total sales were up 7.5% to £800m and, more interestingly, like-for-like growth has quietly accelerated to 3.3% in the most recent 10 weeks. The new Chicken Roll and Matcha launches are clearly doing their job – this business still […]
The Quick Take Company: Gooch & Housego (AIM: GHH) — UK-headquartered specialist manufacturer of photonics components and systems, serving Aerospace & Defence, Industrial and Life Sciences end-markets Thesis: A 77-year-old precision photonics business midway through an operational turnaround — adjusted operating margins moving from 7.7% to 9.6% and targeting mid-teens by 2028 — with a […]
The Quick Take Company: Keller Group (LSE: KLR) — the world’s largest geotechnical specialist contractor Thesis: A 165-year-old industrial that has just had its best year ever, sits in net cash for the first time in 25 years, is returning serious capital to shareholders, and is structurally exposed to four mega-trends (data centres, energy transition, […]
The Quick Take Company: MS International (AIM: MSI) — a UK family-controlled engineering group built around MSI-Defence Systems, a tier-one supplier of naval gun systems and counter-drone air defence to global navies and land forces, with three legacy civilian divisions (Forgings, Petrol Station Superstructures, Corporate Branding) now formally being readied for disposal Thesis: A […]
The Quick Take Company: Ondine Biomedical (AIM: OBI) — Canadian life-sciences group commercialising Steriwave®, a non-antibiotic nasal photodisinfection therapy Thesis: Asymmetric, catalyst-driven AIM venture bet on the first FDA-approvable nasal decolonisation product, anchored by HCA Healthcare’s strategic alignment as trial partner, equity holder and intended commercial channel; UK adoption via Mölnlycke supplies validation but is […]
MTI Wireless Edge (AIM: MWE) — Initiation of Coverage The Quick Take Company: MTI Wireless Edge (AIM: MWE) — Israeli antenna and defence-comms group Thesis: Net-cash AIM compounder mispriced as a sleepy small-cap; the PSK Wind defence pivot is materially under-appreciated Valuation: ~68p vs my fair value of 100p (≈47% upside) Key risk: […]
Q1 Portfolio Update: Navigating Multiple Compression and Sector Rotation The first quarter was defined by a ruthless recalibration of equity risk premiums. Against a challenging macroeconomic backdrop, capital rotated aggressively out of long-duration growth assets and into businesses offering tangible near-term cash flows, robust balance sheets, and pricing power. The portfolio generated an average total […]
Overall, this is a highly reassuring statement. The company has successfully navigated the complexities of its transformational acquisitions (Peters Surgical and Syntacoll) while maintaining top-line momentum in its legacy portfolio. Excellent cash generation which allows for the reduction of debt. I think this would be acquired by a private equity in the next 1 year […]
For investors hunting for high-quality, cash-generative compounding machines on the AIM market, Warpaint London PLC (AIM: W7L) has long been a standout name. Historically known for its flagship “dupe” cosmetics brands, W7 and Technic, the company has carved out a highly profitable niche by offering premium-style beauty products at mass-market price points. However, as we […]